Papalocal
Loading…
Papalocal · Things

Novo is a Danish pharmaceutical company. It was founded in 1923 by Hans Christian Hagedorn, August Krogh and Marie Krogh. Its headquarters are in Bagsværd. Its chief executive is Lars Fruergaard Jørgensen. It has 69,505 employees (2025).

Founded
1923
Founded by
Hans Christian Hagedorn
Headquarters
Bagsværd
Industry
pharmaceutical industry
Chief executive
Lars Fruergaard Jørgensen (2017–)
Employees
69,505 (2025)
All 18 facts, and where they come from

Facts

18 facts · 0 confirmed by two sources · 5 cited · 13 from one source

What it is
business One source
enterprise One source
public company One source
Founded
1923 One source
Founded by
Hans Christian Hagedorn One source
August Krogh One source
Marie Krogh One source
August Kongsted One source
Headquarters
Bagsværd One source
Country
Denmark Cited
Industry
pharmaceutical industry One source
Chief executive
Lars Fruergaard Jørgensen (2017–) Cited
Mike Doustdar One source
Employees
69,505 (2025) Cited
Part of
Novo Holdings One source
Owned by
Novo Holdings (2023) Cited
Novo Nordisk Foundation (2023) Cited
Official website
https://www.novonordisk.com One source

Where this comes from

Papalocal keeps its own record. It started from these sources; what each one said is kept here as it was copied, so a change on their side never changes this page by itself. Tap one to read its version.

What Wikidata says · copied November 17, 2026 · revision 2563129192
Described as
Danish pharmaceutical company
Other names
Novo Nordisk, Novo Nordisk A/S
What it is
business; enterprise; public company · 1 reference
Founded
1923
Founded by
Hans Christian Hagedorn; August Krogh; Marie Krogh; August Kongsted
Headquarters
Bagsværd
Country
Denmark · 1 reference
Industry
pharmaceutical industry
Chief executive
Lars Fruergaard Jørgensen (2017–) · 1 reference; Lars Rebien Sørensen (2000–2016) · 2 references
Employees
42 (2016) · 1 reference
Part of
Novo Holdings
Owned by
Novo Holdings (2023) · 1 reference; Novo Nordisk Foundation (2023) · 1 reference
Official website
https://www.novonordisk.com
Wikipedias with a page
35

Wikidata item Q818846 (wikidata.org/wiki/Q818846), public domain (CC0). Copied 2026-11-17.

What Wikipedia says · copied November 17, 2026 · revision 1384989738

Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily obesity and diabetes medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 69,500 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings (wholly owned by the Novo Nordisk Foundation) which holds 28% of its shares and a majority (77%) of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe.

From the Wikipedia article “Novo (company)” (en.wikipedia.org/wiki/Novo_(company)), by its contributors, under CC BY-SA 4.0 (creativecommons.org/licenses/by-sa/4.0/). Copied 2026-11-17; not changed.

Confirmed Two sources agree. Cited One source, and it names where it got it. One source One source, without a reference of its own. Sources disagree The sources disagree. We show the best-supported value and keep theirs below.

Picture: News Øresund - Johan Wessman, via Wikimedia Commons · CC BY 3.0

People connected 1

Worked here